Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Mills

Showing results (961-970 of 1,298) with videos related to

Pageof 130
Sort By:
Molecular Cancer Therapeutics|October 14, 2011
Dual inhibition of tumor energy pathway by 2-deoxyglucose and metformin is effective against a broad spectrum of preclinical cancer modelsJae-Ho Cheong, Eun Sung Park, Jiyong Liang, et al.
Oncogene|May 10, 2016
The ErbB2ΔEx16 splice variant is a major oncogenic driver in breast cancer that promotes a pro-metastatic tumor microenvironmentJ Turpin, C Ling, E J Crosby, et al.
Journal of Inherited Metabolic Disease|March 25, 2014
Liver disease in infancy caused by oxysterol 7 α-hydroxylase deficiency: successful treatment with chenodeoxycholic acidDongling Dai, Philippa B Mills, Emma Footitt, et al.
Cold Spring Harbor Molecular Case Studies|January 5, 2017
ALK: a tyrosine kinase target for cancer therapyVijaykumar R Holla, Yasir Y Elamin, Ann Marie Bailey, et al.
Nature Communications|November 27, 2025
Aurora kinase B phosphorylates ZBP1 to drive PANoptosis following treatment with PARP and ATR inhibitors combinationWenjian Gong, Zhiqi Liao, Fan Xiong, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 9, 2023
Tropical forests post-logging are a persistent net carbon source to the atmosphereMaria B Mills, Yadvinder Malhi, Robert M Ewers, et al.
Cancer Research|November 3, 2017
"Personalized Cancer Therapy": A Publicly Available Precision Oncology ResourceKatherine C Kurnit, Ann M Bailey, Jia Zeng, et al.
Cell Systems|March 19, 2018
Microenvironment-Mediated Mechanisms of Resistance to HER2 Inhibitors Differ between HER2+ Breast Cancer SubtypesSpencer S Watson, Mark Dane, Koei Chin, et al.
BMC Cancer|February 25, 2014
A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphorylationKimberly C Wiegand, Bryan T Hennessy, Samuel Leung, et al.
Circulation. Cardiovascular Interventions|March 4, 2025
Early Versus Delayed Invasive Management of Female Patients With Non-ST-Elevation Acute Coronary Syndrome: An Individual Patient Data Meta-AnalysisGregory B Mills, Christos P Kotanidis, Shamir Mehta, et al.
Pageof 130

Showing results (961-970 of 1,298) with videos related to

Sort By:
Pageof 130
Molecular Cancer Therapeutics|October 14, 2011
Dual inhibition of tumor energy pathway by 2-deoxyglucose and metformin is effective against a broad spectrum of preclinical cancer modelsJae-Ho Cheong, Eun Sung Park, Jiyong Liang, et al.
Oncogene|May 10, 2016
The ErbB2ΔEx16 splice variant is a major oncogenic driver in breast cancer that promotes a pro-metastatic tumor microenvironmentJ Turpin, C Ling, E J Crosby, et al.
Journal of Inherited Metabolic Disease|March 25, 2014
Liver disease in infancy caused by oxysterol 7 α-hydroxylase deficiency: successful treatment with chenodeoxycholic acidDongling Dai, Philippa B Mills, Emma Footitt, et al.
Cold Spring Harbor Molecular Case Studies|January 5, 2017
ALK: a tyrosine kinase target for cancer therapyVijaykumar R Holla, Yasir Y Elamin, Ann Marie Bailey, et al.
Nature Communications|November 27, 2025
Aurora kinase B phosphorylates ZBP1 to drive PANoptosis following treatment with PARP and ATR inhibitors combinationWenjian Gong, Zhiqi Liao, Fan Xiong, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 9, 2023
Tropical forests post-logging are a persistent net carbon source to the atmosphereMaria B Mills, Yadvinder Malhi, Robert M Ewers, et al.
Cancer Research|November 3, 2017
"Personalized Cancer Therapy": A Publicly Available Precision Oncology ResourceKatherine C Kurnit, Ann M Bailey, Jia Zeng, et al.
Cell Systems|March 19, 2018
Microenvironment-Mediated Mechanisms of Resistance to HER2 Inhibitors Differ between HER2+ Breast Cancer SubtypesSpencer S Watson, Mark Dane, Koei Chin, et al.
BMC Cancer|February 25, 2014
A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphorylationKimberly C Wiegand, Bryan T Hennessy, Samuel Leung, et al.
Circulation. Cardiovascular Interventions|March 4, 2025
Early Versus Delayed Invasive Management of Female Patients With Non-ST-Elevation Acute Coronary Syndrome: An Individual Patient Data Meta-AnalysisGregory B Mills, Christos P Kotanidis, Shamir Mehta, et al.
Pageof 130